Gastroesophageal Cancers

Gastresophagel cancer incidence has increased up to 400%. The introduction of preoperative chemotherapy and first targeted therapies in the treatment of gastroesophageal cancer has influenced prognosis.

Biliary Tract Cancer

Cancer of the biliary tract is the second most common type of cancer to involve the region of the liver. Clinical research are challenging better diagnosis and multimodal tretament concepts.

Colorectal Cancer

Many colon cancer treatment options are available for colorectal cancer, including surgery, chemotherapy, and radiation. The optimal sequence will influence patient´s outcome.

Pancreatic Cancer

The prognosis of pancreatic cancer is still poor. Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy will be in the focus.

Gastrointestinal Stromatumors

GIST is the most common mesenchymal neoplasm of the gastrointestinal tract. Tyrosinkinase inhibitors have been proven in adjuvant or neoadjuvant but also in recurrent stage of disease.

Liver Carcinoma

HCC is currently one of the most common worldwide causes of cancer death, In creating a treatment plan, important factors to consider include function stage

Neuroendocrine Tumors

Factors that determine the clinical course and outcome of patients with GI-NETs are complex. For optimal treatment the input of multiple specialists is inquired.

Bariatric Surgery

Bariatric surgery has been proven as an effective and durable tool in fighting obesity with a dramatic impact on diabetes, hyperlipidemia, hypertension and sleep apnea.


New developments and promising laboratory discoveries for future treatments of cancer patients.

Keynote Speakers

Our Top Speakers on IASGO 2014

Philippe Bachellier France Extended pancreatic resection combined with en-bloc arterial and venous resections for locally advanced cancer: who are best candidates ?
Luciano DeCarlis Italy

Algorithm for management of patients affected by HCC suitable for curative treatments: Liver Transplantation or Liver Resection?

Dave Dietz USA Improving U.S. Rectal Cancer Care: the OSTRICH initiative
Ho-Seong Han Korea Current Status of Laparoscopic Liver Resection
Norihiro Kokudo Japan How can liver surgeons contribute to the development of treatment algorithms for hepatocellular carcinoma?
Nikolaos Lygidakis Greece Conflicts & dilemmas of pancreatic surgery for pancreatic cancer: the challenge of radical resection
Masatoshi Makuuchi Japan Hilar Cholangiocarcinoma-Standard Surgical Procedure
Satoru Murata Japan Interventional management for advanced liver and pancreatic malignancies: percutaneous isolated perfusion therapies
Akimasa Nakao Japan How to prevent gastric congestion after superior mesenteric vein-portal vein confluence resection without splenic vein reconstruction in pancreatoduodenectomy
Pascal Piedbois France Anticancer drugs for tomorrow: What big pharma have in their pipes
Yasuyuki Seto Japan Treatment Strategy for Esophago-Gastric Junction Cancer
Olivier Soubrane France Laparoscopic liver surgery: state-of-the art
Chris Wolfgang USA Genetics, biology and surgery for IPMN
Anusak Yiengpruksawan USA Is radical pancreatectomy possible with Robotic approach?